Professor John C. Gittins and Dr. Anne-Marie Oreskovich are the creators of the Gittins-Oreskovich (GO) risk measures, a set of measures which quantify risk in drug development projects.
Professor Gittins, along with his Oxford research team, including his last doctoral student, Dr. Anne-Marie Oreskovich, also created the Optimizing Pharmaceutical Research Resource Allocation (OPRRA) Software, designed to assist pharma companies in making investment decisions in drug discovery.
Professor Gittins and Dr. Oreskovich formed Gittins & Oreskovich Consulting in 2014, to service clients using both the GO risk measures and OPRRA products, as well as in general pharma risk modeling.
Pharmaceutical Research Risk Modeling
Preclinical Trial R&D Software
News & Articles
Professor Gittins presented the GO research, OPRRA, and the GO risk measures at the 3rd Rutgers Applied Probability Conference on June 6, 2014.
Click here for his slide presentation.
Click here for information about the conference.
Gittins & Oreskovich Consulting was formed.